Vanda Pharmaceuticals Inc.
VNDA | NASDAQ
$5.21
+$0.05 (+1.07%)
Sep 22, 2026, 1:34 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -323.42M | -239.55M | -220.47M | -84.2M | -66.94M | -44.25M | -18.9M | -16.39M | -10.93M | -4.89M | 2.51M | 11.77M | 14.9M | 15.96M | 6.28M | 6.49M | 10.99M | 18.07M | 33.15M | 34.26M | 32.44M | 31.5M |
Depreciation & Amortization | 18.68M | 8.66M | 7.11M | 3.22M | 3.14M | 7.89M | 8.13M | 7.32M | 5.93M | 4.56M | 3.01M | 2.52M | 2.61M | 2.7M | 2.73M | 2.78M | 2.81M | 2.83M | 2.84M | 2.85M | 2.86M | 2.86M |
Stock-Based Compensation | 11.63M | 9.07M | 9.47M | 10.05M | 10.94M | 11.82M | 12.43M | 12.84M | 13.01M | 13.27M | 14.04M | 14.55M | 15.27M | 15.85M | 16.28M | 16.27M | 16.33M | 16.24M | 15.37M | 14.81M | 14M | 13.33M |
Other Working Capital | 10.16M | 4.33M | 3.42M | 11.5M | -4.27M | -11.83M | 4.78M | 2.14M | -1K | -3.77M | 11.72M | 14.09M | 32.75M | 37.96M | -151K | -5.37M | -15.06M | -10.55M | 4.4M | 5.92M | 10.18M | 10.24M |
Other Non-Cash Items | -957K | 3.74M | 4.7M | 6.74M | 4.35M | -2.45M | -4.38M | -4.94M | -5.33M | -5.03M | -4.73M | -4.59M | -3.22M | -1.66M | -507K | 1.16M | 2.67M | 3.22M | 3.37M | 3.41M | 3.33M | 2.45M |
Deferred Income Tax | 97.21M | 89.24M | 81.44M | -23.66M | -20.77M | -14.03M | -6.48M | -12.05M | -6.24M | -3.55M | -1.29M | 6.62M | 2.05M | -1.27M | 1.13M | 2.03M | 6.39M | 10M | 6.75M | 7.83M | 7.08M | 6.47M |
Change in Working Capital | 4.31M | 2.34M | 8.31M | 6M | 4.49M | -15.45M | -6.56M | -4.46M | -1.59M | -15.81M | -747K | -4.92M | 9.22M | 28.16M | 6.07M | 20.46M | 6.55M | 8.7M | 2.74M | -6.26M | -2.82M | 5.27M |
Operating Cash Flow | -192.55M | -126.51M | -109.44M | -81.84M | -64.8M | -56.47M | -15.76M | -17.67M | -5.14M | -11.43M | 12.8M | 25.95M | 40.84M | 59.74M | 31.98M | 49.18M | 45.74M | 59.07M | 64.21M | 56.91M | 56.89M | 61.88M |
Capital Expenditures | -895K | -783K | -998K | -1.11M | -1.11M | -919K | -490K | -529K | -392K | -339K | -383K | -393K | -517K | -655K | -679K | -550K | -392K | -497K | -552K | -1.38M | -1.64M | -1.55M |
Cash Acquisitions | -20M | -10M | n/a | n/a | n/a | n/a | -2.71M | -2.71M | -38.06M | 152.78M | 156.14M | 156.14M | 191.49M | 655K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -16.08M | -69.05M | -112.38M | -202.75M | -272.44M | -332.1M | -364.77M | -327.35M | -290.26M | -425.57M | -512.61M | -461.94M | -584.25M | -433.17M | -349.26M | -450.22M | -399.09M | -406.54M | -420.46M | -397.7M | -392.85M | -398.28M |
Sales Maturities Of Investments | 177.48M | 151.03M | 208.24M | 257.85M | 318.23M | 379.23M | 352.06M | 367.56M | 353.61M | 311.71M | 601.6M | 569.49M | 634.82M | 660.18M | 399.86M | 399.27M | 353.17M | 341.13M | 344.32M | 331.7M | 295.85M | 338.11M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -1.52M | -1.52M | -102.19M | -66.84M | -256.15M | -256.81M | -156.14M | -191.49M | -655K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 140.51M | 71.19M | 94.86M | 53.99M | 44.68M | 44.69M | -17.43M | -65.21M | -41.94M | -217.57M | -12.06M | 107.16M | 50.05M | 226.35M | 49.93M | -51.5M | -46.31M | -65.9M | -76.7M | -67.38M | -98.64M | -61.73M |
Debt Repayment | -3.57M | -2.36M | -1.99M | -1.51M | -989K | -564K | -155K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -915K | -915K | -915K | -915K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -3.57M | -2.36M | -2.91M | -2.42M | -1.9M | -1.48M | -155K | n/a | n/a | n/a | n/a | 605K | 609K | 734K | 734K | 1.17M | 1.54M | 1.7M | 3.55M | 3.94M | 3.69M | 7M |
Net Cash Flow | -55.92M | -57.76M | -17.36M | -30.48M | -21.97M | -13.36M | -33.51M | -82.69M | -47.08M | -229.01M | 792K | 133.79M | 91.81M | 287.24M | 82.96M | -1.13M | 926K | -5.26M | -9.02M | -6.51M | -38.01M | 7.24M |
Free Cash Flow | -193.44M | -127.3M | -110.44M | -82.95M | -65.91M | -57.39M | -16.25M | -18.2M | -5.53M | -11.77M | 12.42M | 25.56M | 40.32M | 59.09M | 31.31M | 48.63M | 45.34M | 58.57M | 63.66M | 55.53M | 55.25M | 60.32M |
Adj. Free Cash Flow | -205.07M | -136.36M | -119.91M | -93M | -76.85M | -69.21M | -28.68M | -31.04M | -18.54M | -25.05M | -1.62M | 11.01M | 25.05M | 43.23M | 15.03M | 32.36M | 29.01M | 42.33M | 48.29M | 40.71M | 41.25M | 47M |
Maintenance CapEx | -632K | -403.62K | -476.78K | -476.78K | -476.78K | -294.16K | -7K | -260K | -284K | -339K | -332K | -342K | -466K | -604K | -679K | -533.47K | -365.47K | -213.42K | -138.42K | -683.81K | -912.7K | -939.85K |
Growth CapEx | -263K | -379.38K | -521.23K | -633.23K | -633.23K | -624.85K | -483K | -269K | -108K | n/a | -51K | -51K | -51K | -51K | n/a | -16.53K | -26.53K | -283.58K | -413.58K | -700.19K | -727.3K | -612.15K |
Owner Earnings | -193.18M | -126.92M | -109.92M | -82.32M | -65.27M | -56.77M | -15.76M | -17.93M | -5.43M | -11.77M | 12.47M | 25.61M | 40.37M | 59.14M | 31.31M | 48.64M | 45.37M | 58.85M | 64.08M | 56.23M | 55.97M | 60.94M |
Add to Watchlist
Select watchlists to add or remove VNDA